Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 10:35 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 2,512 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Healthy
Interventions: Shigella sonnei 53G; Biological
Lead sponsor: PATH; Other
Eligibility: 18 Years to 49 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Substance Use Disorders (SUDs)
Interventions: Cogito digital therapeutics development platform; Other
Lead sponsor: Square2 Systems, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Hanover, New Hampshire

Conditions: HIV Infections, Electronic Health Record, Primary Health Care
Interventions: EMC2 PrEP Educational Tool, Discrete Scheduling of a Dedicated PrEP Visit; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Abdominal Aortic Aneurysm
Interventions: Ovation® Abdominal Stent Graft Platform; Device
Lead sponsor: TriVascular, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: Phoenix, Arizona • Houston, Texas

Conditions: Intracerebral Hemorrhage
Interventions: Arctic Sun cooling device, Standard of Care; Device · Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: HIV
Interventions: Community Events, Social Network HIV Testing, Peer Network Intervention; Behavioral
Lead sponsor: City University of New York; Other
Eligibility: 18 Years and older
Enrollment: 840 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Diabetes, Hypertension, High Cholesterol/Hyperlipidemia, Coronary Artery Disease, Congestive Heart Failure, Chronic Lung Disease, Chronic Kidney Diseases, Arrythmia, Stroke, Depression, Anxiety, Pulmonary Embolism, Heart Attack
Interventions: Med AAAction intervention; Other
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years and older
Enrollment: 388 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Knoxville, Tennessee • Memphis, Tennessee

Conditions: HIV Infections
Interventions: Not listed
Lead sponsor: Baystate Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,087 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Springfield, Massachusetts

Conditions: Sepsis, Emergency Medical Services, Quality Improvement, Shock, Septic, Fluid Therapy
Interventions: Incorporation of Rapid Fluid Infusion Device in Prehospital Suspected Sepsis Protocol, Conventional Prehospital Suspected Sepsis Protocol; Other
Lead sponsor: Orange Park Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Orange Park, Florida

Conditions: Major Depression
Interventions: AV 101 (4-Chlorokynurenine), Placebo Comparator; Drug · Other
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Low Cardiac Output
Interventions: Not listed
Lead sponsor: University of Iowa; Other
Eligibility: 30 Years to 90 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Small Bowel Obstruction, Gastrointestinal Hemorrhage
Interventions: RightSpot pH Indicator, Chest radiograph; Device · Radiation
Lead sponsor: RightBio Metrics; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Healthy
Interventions: MitoQ, Placebo, MitoTempo, Tempol, L-NAME, SNP - Sodium Nitroprusside; Dietary Supplement · Drug
Lead sponsor: University of Georgia; Other
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Athens, Georgia

Conditions: Spinal Cord Injuries, Cardiovascular Diseases, Endothelial Dysfunction
Interventions: Brachial intra-arterial infusion of vasoactive and antioxidant drugs (acetylcholine, nitroprusside, ascorbic acid), venous occlusion plethysmography, Acetylcholine, Sodium Nitroprusside, Ascorbic acid, venous phlebotomy; Procedure · Drug
Lead sponsor: Craig Hospital; Other
Eligibility: 18 Years to 89 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Englewood, Colorado

Conditions: HIV-1
Interventions: D/C/F/TAF FDC, TAF/FTC FDC, INI Based Regimen; Drug
Lead sponsor: Janssen Scientific Affairs, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 34
States / cities: Birmingham, Alabama • Bakersfield, California • Beverly Hills, California + 28 more

Conditions: Hepatic Impairment
Interventions: Omaveloxolone 50 mg capsules; Drug
Lead sponsor: Biogen; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 3
States / cities: Tustin, California • Miami, Florida • Orlando, Florida

Conditions: Diabetes, Retinal Disorders
Interventions: Pupillometry testing.; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 315 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2015
U.S. locations: 2
States / cities: Los Angeles, California • Pittsburgh, Pennsylvania

Conditions: Rare Diseases
Interventions: Rapid whole genome sequencing; Genetic
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 1 Day to 90 Days
Enrollment: 410 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Desaturation, Bradycardia, Tachycardia, Hypertension, Hypotension
Interventions: Rapid Response Team; Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Atrial Fibrillation, Atrial Flutter
Interventions: Oral, Intravenous drug; Drug
Lead sponsor: Corewell Health South; Other
Eligibility: 18 Years and older
Enrollment: 444 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Saint Joseph, Michigan

Conditions: Post Traumatic Stress Disorder
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS), Cognitive Processing Therapy, Repetitive Transcranial Magnet Stimulation (rTMS); Device · Behavioral
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 18 Years to 60 Years
Enrollment: 103 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Dystonia, Focal, Task-specific
Interventions: rTMS, Sham rTMS; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 21 Years to 75 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Cancer, Pediatric Cancer
Interventions: Questionnaire, Physical Exam; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 30 Days to 30 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 3
States / cities: Aurora, Colorado • Portland, Oregon

Conditions: Reversal of Coagulopathy
Interventions: Beriplex® P/N (Kcentra), Fresh frozen plasma; Biological
Lead sponsor: CSL Behring; Industry
Eligibility: 18 Years and older
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 16
States / cities: Newark, Delaware • Lexington, Kentucky • Boston, Massachusetts + 13 more

Search by objective public record fields.

Dose-Finding Study of Lyophilized Shigella Sonnei 53G Challenge Strain

Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics

An Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy

LIFE Study: Least Invasive Fast-Track EVAR

Systemic Normothermia in Intracerebral Hemorrhage (ICH)

Adaptation and Implementation of Project Encuentro in the U.S.-Mexico Border

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

HIV Testing in the Emergency Department at Baystate Medical Center: A Pilot Program

Orange Park Out-of-Hospital Quality Improvement Study for Improving CMS Sepsis Core Measures

Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder

Comparison of Cardiac Output With LiDCO Rapid and TEE Against Thermodilution Technique in Cardiac Surgery

Nasogastric/Orogastric Tube Placement Verification Study Using RightSpot pH Indicator to Verify Gastric Acidity

Effects of an Antioxidant Supplement on Blood Vessel Health

Role of Endothelial Function in SCI CVD Risk

A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain

A Pharmacokinetic Study of Omaveloxolone in Subjects With Hepatic Impairment and Normal Hepatic Function

Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device)

Genetic Study to Determine the Cause of Birth Defects in Newborns in Texas

NTX Wireless Patient Monitoring System

Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation

Novel Treatment of Emotional Dysfunction in Post Traumatic Stress Disorder (PTSD)

Repetitive Transcranial Magnetic Stimulation for the Treatment of Focal Hand Dystonia

Integrative Health Interventions in Symptom Management of Pediatric Patients

An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure